%0 Journal Article
%T Nano-curcumin improves glucose indices, lipids, inflammation, and Nesfatin in overweight and obese patients with non-alcoholic fatty liver disease (NAFLD): a double-blind randomized placebo-controlled clinical trial
%A Milad Daneshi-Maskooni
%A Mohammad-Javad Hosseinzadeh-Attar
%A Mostafa Qorbani
%A Seyed Ali Jazayeri-Tehrani
%A Seyed Mahdi Rezayat
%A Seyed Moayed Alavian
%A Siavash Mansouri
%J Archive of "Nutrition & Metabolism".
%D 2019
%R 10.1186/s12986-019-0331-1
%X Flowchart of participants with overweight/obesity and NAFL
%K Non-alcoholic fatty liver disease
%K Nano-curcumin
%K Obesity
%K Overweight
%K Iran
%U https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6348610/